← All stocks

ARDELYX, INC.

ARDX No buying or selling
CIK 0001437402 #2545 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

19 insiders · 0 transactions
7.8×

Michael Raab holds 7.8 times base salary in stock. $6.25M of shares against $797.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Raab last reported holding, valued at $3.86, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
MOTT DAVID M
Director
3,349,655
$12.92M
+176.9%
RAAB MICHAEL
President & CEO
1,619,792
$6.25M
+32.3%
Rosenbaum David P.
Chief Development Officer
448,378
$1.73M
−11.2%
Rodgers Richard J
Director
439,998
$1.70M
+75.6%
Foster Eric Duane
Chief Commercial Officer
409,410
$1.58M
+120.8%
Renz Justin A
Chief Financial Officer
409,052
$1.58M
+37.7%
Williams Laura A
Chief Patient Officer
367,456
$1.42M
+15.6%
Kelliher Mike
Chief Business Officer
349,660
$1.35M
+118.5%
Bertrand William C JR
Director
329,507
$1.27M
+43.4%
Bishop John E
See Remarks
317,095
$1.22M
+45.5%
Blanks Robert
See Remarks
314,421
$1.21M
−1.5%
GRAMMER ELIZABETH A
See Remarks
299,895
$1.16M
+55.9%
Brady James Parker
Chief Human Resources Officer
245,930
$948.53K
+48.2%
Hohenleitner Susan
Chief Financial Officer
227,520
$877.52K
+54.9%
Cadoret-Manier Onaiza
Director
178,156
$687.13K
+61.7%
Bhanji Muna
Director
163,808
$631.79K
+71.0%
Reilly Joseph James
See Remarks
145,854
$562.54K
+18.2%
Parsey Merdad
Director
83,746
$323.00K
Bazemore Robert B
Director
68,006
$262.29K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 21 Sep 2016